Sanofi developed anti-dengue vaccine - Denguvaxia

Sanofi developed anti-dengue vaccine - Denguvaxia
Over several decades, many measures were taken by the local and global parties to avoid dengue. But series of recent outbreaks was experienced due to rainfall that caused increased inundation of contaminant water here and there throughout the cities and rural areas. Sanofi Pasteur, a French-based company has witnessed that, dengue can be seriously avoided by the vaccine called Denguvaxia. This is the historical milestone said the CEO of Sanofi. The vaccine can prevent the people of 9-40 age groups from all four subtypes of dengue virus.
How to cite this article:
Baskar Viswanathan. Sanofi developed anti-dengue vaccine - Denguvaxia. BioLim O-Media. 07 April, 2017. 5(4).
Available from: http://archive.biolim.org/omedia/read/BOMA0222.